Deregulated transcription factor (TF) activities are commonly observed in hematopoietic malignancies. Understanding tumorigenesis therefore requires determining the function and hierarchical role of individual TFs. To identify TFs central to lymphomagenesis, we identified lymphoma type-specific accessible chromatin by global mapping of DNaseI hypersensitive sites and analyzed enriched TFbinding motifs in these regions. Applying this unbiased approach to classical Hodgkin lymphoma (HL), a common B-cell-derived lymphoma with a complex pattern of deregulated TFs, we discovered interferon regulatory factor (IRF) sites among the top enriched motifs. High-level expression of the proinflammatory TF IRF5 was specific to HL cells and crucial for their survival. Furthermore, IRF5 initiated a regulatory cascade in human non-Hodgkin B-cell lines and primary murine B cells by inducing the TF AP-1 and cooperating with NF-κB to activate essential characteristic features of HL. Our strategy efficiently identified a lymphoma type-specific key regulator and uncovered a tumor promoting role of IRF5.
T ranscription factor (TF) activities have to be tightly controlled because their aberrant regulation alters tissue-specific gene expression programs and contributes to cancer pathogenesis. Therefore, the identification of altered TF activities in malignancies is of crucial importance to understand malignant transformation and to develop new treatment strategies. Deregulated TF activities are commonly observed in hematopoietic malignancies including human lymphomas and leukemias, and the link between structural or functional alterations in TFs and malignant transformation has been documented in various in vitro and in vivo studies (1) (2) (3) . Apart from the direct modulation of cellular processes like cellular growth or cell death, alterations of the activity of even single TFs might enforce malignant transformation by switching differentiation programs and consequently altering the cellular fate of the respective cells, as exemplarily demonstrated for the B-lymphoid TF PAX5 (4, 5) .
Among lymphoid malignancies, one of the most prominent examples for complex patterns of deregulated TFs is classical Hodgkin lymphoma (HL), a common B cell-derived malignancy (6) . Pathogenic hallmarks of the malignant Hodgkin/Reed-Sternberg (HRS) cells of HL include the constitutive activation of TFs that are only transiently activated in normal B cells, such as nuclear factor kappa B (NF-κB) or activator protein-1 (AP-1), and a profound deregulation of lineage-specific TFs such as E2A (6) (7) (8) . Thus, although originating from B-lymphoid cells, HRS cells have lost their B cell-specific gene expression pattern and instead upregulate expression of genes characteristic for other hematopoietic lineages. However, the nature of the TFs initiating and maintaining HRS-specific gene expression remains poorly understood.
As an unbiased approach for the identification of deregulated TF activities central to lymphoma biology, we identified HL-specific accessible chromatin regions by global mapping of DNaseI hypersensitive sites (DHSs). DHSs mark cis-regulatory elements bound by TF complexes (9) and differ between normal and malignant cells (10, 11) . We then performed an unbiased genomewide search for TF binding motifs enriched within HRS-specific
Significance
Human lymphomas and leukemias are characterized by molecular and structural alterations of transcription factors (TFs). The identification of such deregulated TFs is therefore central to the understanding of lymphomagenesis. We addressed this question in classical Hodgkin lymphoma (HL), a common B-cellderived malignancy that is one of the most prominent examples for complex patterns of deregulated TFs including the activation of NF-κB or AP-1 and a profound deregulation of lineagespecific TFs. We found that IRF5 together with NF-κB induces a number of HL characteristic features in non-Hodgkin cells, such as expression of cytokines and chemokines or AP-1 activation. Our work exemplifies how the global lymphoma typespecific characterization of TF activities can improve the understanding of tumor biology.
accessible chromatin and functionally analyzed the role of the corresponding factors. The identification of binding motifs for the TFs AP-1, NF-κB, and STAT in HL-specific accessible chromatin confirmed their essential role for HL biology (6) . In addition, we revealed that IFN regulatory factor (IRF) binding motifs are among the top enriched motifs in HL. We detected in HRS cells an abundant expression and increased activity of IRF5, which is an IRF TF family member that plays a central role in Toll-like receptor (TLR)-mediated immune responses and is a key regulator of TLR-induced proinflammatory gene expression (12, 13) . IRF5 directed HL-specific cytokine expression in cooperation with NF-κB and protected HRS cells from cell death. Alone or in combination with NF-κB, IRF5 was capable of inducing gene expression alterations in non-Hodgkin and primary murine splenic B cells that were reminiscent of those found in HL. Furthermore, we identified a transcriptional cross-talk between IRF5 and AP-1, as IRF5 directed the activation of the known abundant and HL-specific AP-1 complex. These data describe a powerful method for the identification of deregulated TF activities in human lymphoma, which led to the identification of IRF5 as a key regulator of HRS cell biology.
Results
Definition of an HL-Specific Active Chromatin Landscape. To identify transcriptional key regulators of HL biology, we mapped DHSs in both Hodgkin and non-Hodgkin cells, followed by the functional analysis of TFs binding to corresponding TF binding motifs enriched within lymphoma type-specific accessible chromatin (Fig. 1A) . Due to the low number of HRS cells in affected lymph nodes (6), we applied this strategy to three classical HLderived cell lines (L1236, L428, and L591; in the following referred to as HRS cell lines) in comparison with two non-Hodgkin B-cell lines (Reh and Namalwa; in the following referred to as non-Hodgkin or NH cell lines; Fig. 1 and SI Appendix, Fig. S1 and Table S1 ). These cell lines have been successfully used for the identification of key molecular and genomic defects in HL (8, 14, 15) . Permeabilized cells were treated with DNaseI, and small genomic fragments were isolated and subjected to next-generation sequencing (DNaseI-Seq) (16) . DNaseI-Seq patterns for selected genes are shown in Fig. 1B and SI Appendix, Fig. S1A . We next determined the ratio of tag counts at DHSs between pairs of HRS and NH cell lines and ranked them according to their change in DNaseI-seq signal (Fig. 1C) . We concentrated on distal (nonpromoter) sites, as they comprise the majority (about 75-80%) of all DHSs. Many of these elements are enhancers that are more likely to bind tissue-specific factors than promoters (17) . The DHS rankings compared with the NH cell lines revealed highly similar DHS accessibility profiles for each of the three HRS cell lines (Fig. 1C) . We next divided DHSs into three groups, based on fold change ( Fig. 1D and SI Appendix, Fig.  S1B ): 7,800 NH-specific peaks (marked in green as A); 12,027 shared peaks (marked in black as B); and 6,959 HRS-specific peaks (marked in red as C). To validate the functional relevance of these data with respect to gene expression, we identified the genes closest to the respective DHSs and determined their corresponding mRNA expression level in HRS cell lines by mining microarray expression data ( Fig. 1 E and F and SI Appendix, Fig.  S1 C-E). In agreement with the requirement of accessible chromatin for ongoing transcription, genes associated with HRSspecific DHSs displayed a higher expression level in HRS than in NH cell lines, irrespective of which HRS was compared with which NH cell line. For both distal and promoter DHSs, the fold increase in HRS-specific nuclease accessibility correlated well with relative gene expression levels (Fig. 1G) . Furthermore, promoter DNA methylation levels showed an expected inverse correlation with accessibility at promoter and nearby distal DHSs in L1236 and L428 HRS cell lines ( Fig. 1H and SI Appendix, Fig.  S1 F and G). Taken together, these data defined a specific active chromatin landscape in HRS cells.
Identification of TF-Binding Motifs Enriched in HRS Cell-Specific
Accessible Chromatin Regions. To identify TFs responsible for the HRS-specific gene expression program, we searched for TF DNA binding motifs specifically enriched in HRS-specific DHSs, using both L1236 and L428 cells as references ( Fig. 2 A and B) . In the B (NH)-specific DHS signature ( Fig. 1D; A) , binding motifs for TFs important for the B-cell program such as E-box and OCT motifs (18) were enriched ( Fig. 2 A and B) , in accordance with their role in maintaining the B-cell phenotype. In contrast, HRS-specific DHSs ( Fig. 1D ; C) were enriched in binding motifs for members of the inducible TF families AP-1, NF-κB, STAT, and IRF ( Fig. 2 A and B) , whereas, as previously demonstrated (19) , TF motifs important for the B-cell program were found with decreased frequency. Mapping the different binding motifs back to enriched sequences showed their association with NH-or HRS-specific DHSs, respectively, and demonstrated that they clustered around the central position of the DHS (SI Appendix, Fig. S2 A-D) . Motif distribution was not random, as AP-1, STAT, and IRF motifs showed a preferred distance with respect to the NF-κB binding motif (SI Appendix, Fig. S2E ). A comparison of the DNaseI cutting frequency at the binding motifs for AP-1, NF-κB, and IRF across all HRS-and NH-specific, as well as shared DHSs, revealed that these motifs were protected from DNaseI digestion in HRS cells only, suggesting that they were occupied by a protein complex ( Fig. 2 C  and D) . In contrast, RUNX sites were not protected in any of the analyzed cell types, and CTCF sites were only protected in DHSs shared between HRS and NH cells, in accordance with an invariant binding of CTCF in different blood cell types (20) .
Abundant IRF5 Expression and Activation in HRS Cells. AP-1, NF-κB, and STAT TFs play an important role in HL pathogenesis (6) , and our data confirmed their crucial role in shaping active chromatin in HRS cells. Because IRF binding motifs ranked among the top motifs within HRS-specific DHSs, we investigated IRF expression and function in HL in detail. First, we determined mRNA expression of all known human IRF genes, IRF1-IRF9, in HRS and NH cell lines (Fig. 3A, Upper) . IRF1-IRF3 and IRF6-IRF9 were expressed at similar levels in all cell lines, whereas IRF8 expression appeared to be lower in HRS cell lines (Fig. 3A, Upper) . IRF4 was robustly expressed in HRS cells as described, but not exclusively (21) . Notably, IRF5 was highly expressed in all of the HRS cell lines in accordance with previously published microarray data (22) . The IRF5 expression levels exceeded that in non-Hodgkin cell lines including ABC-type diffuse large B-cell lymphoma (DLBCL) cell lines, in which IRF5 mRNA expression has been shown previously (22) (Fig. 3A and SI Appendix, Fig. S3A ). We confirmed an activation of the IRF5 locus in HRS cells at the chromatin level (SI Appendix, Fig. S3 B-E), demonstrating an increase in DNaseI accessibility across the entire IRF5 5′-regulatory region (SI Appendix, Fig. S3B ), an enrichment of histone H3 lysine 4 trimethylation (H3K4me3) (SI Appendix, Fig. S3C ), and the presence of RNA polymerase II (RNA-Pol II) (SI Appendix, Fig. S3D ), reflecting ongoing transcription; in contrast, the repressive H3K9me3 mark was absent (SI Appendix, Fig. S3E ). In NH cell lines, the IRF5 gene displayed only limited accessibility with low-level enrichment of RNA-Pol II and H3K4me3 (SI Appendix, Fig. S3 B-E), which is consistent with a primed state for an inducible gene. Northern blotting analysis showed abundant and selective expression of two major IRF5 variants (23) in HRS cell lines (SI Appendix, Fig. S3F ), corresponding to high IRF5 protein expression (Fig. 3A, Lower) . IRF TFs are activated by phosphorylation in the cytoplasm and subsequent translocation into the nucleus (24, 25) . In HRS cell lines, we found IRF5 activation as indicated by its nuclear localization (Fig. 3A, Lower) and the presence of DNA-binding IRF5 complexes ( Fig. 3B and SI Appendix, Fig. S3 G-I) . We confirmed HL-specific IRF5 expression by immunohistochemistry of various primary human lymphomas. IRF5 was abundantly and consistently detectable in the nucleus and cytoplasm of HRS cells (37 of 38 HL cases) and was absent in the vast majority of non-Hodgkin lymphomas (Fig. 3C and SI Appendix, Fig. S3J and GCB-type DLBCL. Furthermore, IRF5 expression in HRS cells was stronger than that observed in tonsils of patients with EBVcaused infectious mononucleosis (SI Appendix, Fig. S3J ).
IRF5 Controls Cytokine Activation in HRS Cells and Protects Them
from Cell Death. IRF5 attracted our attention because it orchestrates the transcriptional activation of proinflammatory genes in response to various stimuli (12, 26) , and a broad activation of proinflammatory response genes is a unique hallmark of HL (6) .
To define the role of IRF5 in establishing the proinflammatory phenotype of HRS cells, we first determined the mRNA expression levels of a panel of cytokine, chemokine, and chemokine receptor genes in the various cell lines. We included in this analysis the TFs JUN, a known regulator of cytokine expression, and LPS-induced TNF-α factor (LITAF), which mediates LPSinduced cytokine and chemokine activation, and the LPS/IRFinducible chemokine gene CXCL11, the latter two genes not yet analyzed in HRS cells (Fig. 3D ). All these genes were consistently expressed in HRS but not in NH cell lines. IRFs and NF-κB can form a multiprotein complex that is required for full target gene activation (13, 27) . Given that persistent activation of NF-κB is a key pathogenic feature of HRS cells (6), we speculated that their unusual cytokine and chemokine production resulted from IRF5 activation in combination with NF-κB. To explore this possibility, we analyzed in HRS cell lines the activities of wild-type (WT) or mutated reporter Fig.1D were analyzed for the presence of enriched TF binding motifs. (C and D) Digital footprinting using average DNaseI cutting frequencies ± 100 bp around the HRS-enriched binding motifs IRF, NF-κB, and AP-1 for (C) L1236 vs. Reh and (D) L428 vs. Namalwa (red and green, respectively) in HRS-specific, shared (invariant), and NH-specific DHSs, corresponding to groups A, B, and C. Note the differences in average DNaseI cutting frequency in DHSs specific for HRS and NH cell lines and the reduction in cutting frequency around the motif centers. RUNX and CTCF motifs were examined as controls demonstrating (i) equal digestion around RUNX motifs in DHS of all cell types and (ii) increased digestion around CTCF motifs only within shared DHS.
constructs of the RANTES promoter (RANTES P), which contains an IFN-stimulated response element (ISRE) and an NF-κB binding site (27) (Fig. 3E ). In accordance with the high RANTES mRNA expression in these cells (Fig. 3D) , the WT construct was highly active (Fig. 3E) . ISRE mutation reduced promoter activity, and mutation of the NF-κB site reduced activity to basal levels. Furthermore, cotransfection with the NF-κB superrepressor IκBαΔN (28) reduced activities of the WT-and ISRE-mutated RANTES P constructs (Fig. 3E) , suggesting a cooperative activity of IRFs and NF-κB in HRS cell lines. To determine the impact of IRF5 and NF-κB on the endogenous expression of proinflammatory genes in HRS cells, we inhibited both factors by cotransfecting the dominant-negative variants DNIRF5-4D (24) and IκBαΔN, respectively ( Fig. 3F and SI Appendix, Fig. S4 A and B) . Transfection of DNIRF5-4D and IκBαΔN independently reduced IL13, IL6, and RANTES mRNA expression, and both in combination resulted in a more pronounced reduction in mRNA expression ( Fig. 3F and SI Appendix, Fig. S4A ). These effects were confirmed by analyzing IL-6 and RANTES protein expression in supernatants of transfected HRS cell lines (SI Appendix, Fig. S4C ). In addition to controlling the expression of these proinflammatory genes, IRF5 was essential for HRS cell viability. Following transient IRF5 knockdown One of four independent experiments is shown. P values are shown for the comparisons to the respective WT reporter activites or the Mock controls, respectively. *P < 0.05; **P < 0.01; ***P < 0.001.
using specific small-interfering (si)RNAs, we observed an induction of cell death of ∼35-50% of the transfected HRS cell population ( Fig. 3G and SI Appendix, Fig. S4 D and E) . The analysis of the cells by Annexin-V/propidium iodide (PI) and active caspase-3 staining indicated that cell death occurred by induction of apoptosis (SI Appendix, Fig. S4 F and G).
IRF5 Together with NF-κB Activates an HRS Cell-Like Inflammatory
Gene Expression Pattern in Non-Hodgkin Cells. Our results prompted the question of whether IRF5 alone or in combination with NF-κB was sufficient to induce the HL characteristic proinflammatory gene expression program. In a subsequent series of experiments, we therefore mimicked the HRS-cell-characteristic activities of IRF5 and NF-κB by introducing the constitutively active variants IRF5-4D (29) and IKKβ(EE) (30) , respectively, into non-Hodgkin cells. In HEK293 cells, either IRF5 or NF-κB activation activated the RANTES P construct, but both together induced a dramatic synergistic activation (SI Appendix, Fig. S5A ).
We confirmed the synergistic activation of endogenous proinflammatory gene expression in the IRF5-4D-and/or IKKβ(EE)-transfected NH cell lines Reh and BJAB (Fig. 4 and SI Appendix, Fig. S5 B and C). Although IRF5-4D or IKKβ(EE) alone induced a subset of proinflammatory genes in both cell lines, full activation of most genes to HRS-cell-like expression levels required their combined activity. We demonstrated this synergistic induction exemplarily for RANTES and IL-6 also at the protein level ( Fig. 4B and SI Appendix, Fig. S5B ). Functionally, the production of cytokines and chemokines following transfection of NH cell lines (Fig.  4A ) led to an increased attraction of mononuclear cells (Fig. 4C ), in accordance with the chemoattraction of various normal hematopoietic cells by HRS cells (6) . Finally, we performed microarray profiling of IRF5-4D-, IKKβ(EE)-, and IRF5-4D-together with IKKβ(EE)-transfected Reh cells and subsequent gene set enrichment analysis (GSEA). Evaluation of HRS signatures based on genes specifically up-regulated in HRS cell lines (Fig. 4D and SI Appendix, Table S3 ) and primary HRS cells (SI Appendix, Fig.  S5C and Table S3 ) revealed a significant enrichment of the HRS signature in IRF5-4D or IKKβ(EE) single transfectants, with the highest enrichment following transfection of both factors in combination ( Fig. 4D and SI Appendix, Fig. S5C ). 
TFs chemokines/ chemokine-r. cells, we infected purified murine splenic B cells with control (Mock) or IRF5-4D encoding retroviruses (Fig. 5 and SI Appendix, Fig. S5 D and E) . We characterized IRF5-4D-induced gene expression changes by microarray analyses and evaluated the HRS signature by GSEA (Fig. 5A and SI Appendix, Fig. S5D ). This analysis revealed a significant enrichment of the up-and down-regulated genes of the HRS signature in IRF5-infected B cells. Apart from the induction of proinflammatory genes, IRF5-induced gene deregulation affected B cell-associated genes and TFs, as demonstrated for down-regulation of AICDA and the TFs EBF1, PRDM1, and XBP1, as well as their antagonists, as shown for the upregulation of ABF1 and ID2 (7) in a HRS-cell-characteristic manner (Fig. 5B) . Other typical features of HRS cells were also recapitulated by IRF5 activity such as up-regulation of CD30 (also called TNFRSF8) or the c-MET tyrosine-kinase receptor and silencing of the epigenetic regulator CBFA2T3 (31) (Fig. 5B) . We next focused on the analysis of the TF AP-1, whose deregulation is a molecular hallmark of HRS cells (28) . In agreement with the up-regulation of JUN in NH cell lines (Fig. 4A) , IRF5-4D caused a strong induction of AP-1 DNA binding activity (Fig. 5C ). The binding intensity and aberrant migration pattern of the IRF5-induced AP-1 complex closely resembled that observed in HRS cells (28) , as demonstrated by supershift analyses with JUN antibodies (Fig. 5D ). In line with these observations, IRF5-4D induced the AP-1/CREB factor genes JUN, JUNB, and ATF3, which encode three main components of the HL-specific AP-1 complex (28, 32) , at the transcriptional level (Fig. 5E) , indicating that AP-1 is a downstream effector of IRF5.
Discussion
The genome-wide mapping of DHSs has been used successfully to characterize cell type-specific regulatory elements, as well as occupied TF binding motifs within these regions (33, 34) . Only recently, the comparison of DHSs in various normal and malignant cell types revealed characteristic reprogramming patterns of the epigenome in distinct cancer entities including hematopoietic malignancies (10, 11) . Here, we extended such analyses by combining the definition of cell type-specific accessible chromatin regions with the functional characterization of TFs binding to enriched binding motifs in such regions.
In the HRS-specific DHSs, we identified enriched binding motifs particularly for inducible TFs including NF-κB, STAT, AP-1, and IRFs. For NF-κB, STAT, and AP-1 factors, an important role not only for lymphomagenesis in general but also for the pathogenesis of HL has been already established (6) . For example, NF-κB and STATs are required for growth and survival of the HRS cells, and various genomic defects in respective pathway components confirm their essential role for HL pathogenesis (6) . Our data confirm their important role for HRS-specific gene regulation and, vice versa, validated our experimental approach. Given the established importance of these factors for HL biology, we focused in this work on IRF factors, which have important functions in the differentiation and transformation of hematopoietic cells (13) .
HL represents a lymphoid malignancy with highly complex TF alterations and dramatic changes of the lymphoid-specific gene expression program. The most important result from this study is therefore that the deregulated activity of only a few TFs might be sufficient to initiate this program. The constitutive activity of IRF5 protects HRS cells from cell death and in combination with NF-κB, IRF5 induces key aspects of the HRS-cell-characteristic gene expression program. Even in primary splenic B cells, IRF5 activation results in the abundant induction of proinflammatory genes (6), the down-regulation of genes required for initiation and maintenance of the B-lineage differentiation program including terminal plasma cell differentiation, and the upregulation of their transcriptional antagonists. Moreover, IRF5 promotes the HL-characteristic silencing of the epigenetic regulator CBFA2T3, which is involved in the aberrant activation of DNA long terminal repeat regions in HRS cells (8) .
We also identified AP-1 as a downstream effector of IRF5. AP-1 deregulation has been recognized as a hallmark of HRS cells, being involved in the HRS cell-specific deregulation of CD30 (35) , the immunomodulatory gene LGALS1 (also called galectin-1) (36), and their unique dedifferentiation process (7, 8) . In HRS cells AP-1 is activated by an unusual mechanism, as its activation is partly MAPK independent (28, 37) , and it is primarily composed of JUN and ATF subunits instead of JUN and FOS (28, 32) . The IRF5-mediated transcriptional activation of the AP-1 complex described here positions IRF5 upstream of AP-1 in the transcriptional hierarchy in HRS cells and provides a molecular explanation for the thus far poorly understood AP-1 activation in HL. Whether the IRF5-mediated gene expression alterations, including the induction of the various cytokines and chemokines, modify the constitutive NF-κB activity in HRS cells, which is in part mediated by secreted factors (38) , remains to be investigated.
The comparison of the DHSs data of HL and NH cells, as well as an Epstein Barr virus (EBV)-transformed lymphoblastoid cell line dataset from the Encyclopedia of DNA Elements (ENCODE), highlighted an HRS-specific active chromatin landscape. This finding indicates that, although EBV infection is linked to HL pathogenesis (6, 39) , it is per se not sufficient to reprogram the epigenome of B-lymphoid cells toward a HRS cell-like conformation. Furthermore, the HL-specific epigenetic landscape significantly correlated with the gene expression pattern in the various HRS cell lines, including those of T-cell origin (HDLM-2 and L540). This result suggests that a common transformation process with dominant transcriptional alterations leads to the HL phenotype rather than that the HL gene expression pattern reflects that of a putative physiological counterpart.
The important role of IRF5 in the orchestration of the HL-specific gene expression program points toward potential initiating events in this disease. In innate immunity, IRF5 is positioned downstream of pattern recognition receptors (PRR) (13) and is required for the induction of various inflammatory mediators. For example, IRF5
−/− mice are resistant to LPS-induced lethal shock, emphasizing the role of IRF5 in the coordination of innate immune responses (12, 24, 26, 40) . In addition, IRF5 gene polymorphisms and expression alterations have been linked to autoimmune and inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases (12, 41, 42) . With respect to IRF5 activation, an involvement of MyD88-dependent signaling complexes following TLR activation and a role of the IKK-related kinases TBK1 and IKKe have been described (12, 43) . Thus, in HRS cells, high-level IRF5 expression might be a result of constitutive PRR activation, a hypothesis that can now be experimentally tested.
Full target gene induction by IRF5 requires the cooperation with other TFs or coactivators (13, 44, 45) . In line with these data, we observed a strong transcriptional synergism of IRF5 with NF-κB, which only in this combination resulted in full activation of a whole set of proinflammatory genes in NH cells. Our data indicate that this synergism is the basis for the abundant production of cytokines and chemokines in HRS cells, as NF-κB activation alone can be observed in a variety of other hematopoietic malignancies, which, however, lack the widespread and abundant activation of proinflammatory genes characteristic for HL. It remains to be investigated how IRF5 and NF-κB coordinate the protection of HRS cells from apoptotic cell death, and whether other transcription factors aberrantly activated in HL, such as GATA3 (7, 46) , AP-1, or the here described LITAF, contribute to full induction of proinflammatory genes in HL.
Together, our studies uncovered a key role of IRF5 in a lymphoid malignancy with a unique inflammatory phenotype and exemplifies how the global lymphoma type-specific identification of aberrant TF activities can improve the understanding of tumor biology.
Methods
Cell Lines, Culture Conditions, and Transfections. HRS [L428, L1236, KM-H2, L591 (EBV + ), HDLM-2, L540, L540Cy], pro-B lymphoblastic leukemia (Reh), Burkitt´s lymphoma (Namalwa, BL-60, BJAB), diffuse large B-cell lymphoma (OCI-Ly3, OCI-Ly10, HBL1, TMD8, HT, OCI-Ly1, OCI-Ly7, OCI-Ly19, SU-DHL-4), and HEK293 cell lines were cultured as previously described (8) . Cells were electroporated (EP) in OPTI-MEM I using Gene-Pulser II (Bio-Rad) with 950 μF and 0.18 kV (L428, L1236, L540Cy, BJAB, HEK293), 50 μF and 0.5 kV (KM-H2), and 500 μF and 0.3 kV (Reh, L591). DNA Constructs. Expression constructs pcDNA3-IκBαΔN and pRK5-IKKβ(EE) and luciferase reporter constructs pGL3-RANTES P WT, pGL3-RANTES P-ISRE mut, and -NF-κB mut have been previously described (8, 27, 28) . To generate the pcDNA3-FLAG-IRF5-4D expression construct, full-length human IRF5 cDNA (GenBank accession no. U51127) was cloned with N-terminal FLAG epitope into pcDNA3 (Invitrogen). Activating mutations according to Lin et al. (29) were introduced by site-directed mutagenesis using the QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene). pcDNA3-FLAG-DNIRF5-4D lacks AA 1-137, which comprise the N-terminally located nuclear localization signal and the DNA binding domain and was cloned through BamHI and EcoRI restriction sites into pcDNA3-FLAG from pcDNA3-FLAG-IRF5-4D. For cloning of the retroviral expression construct MSCV-IRF5-4D-IRES-CFP, the plasmid pcDNA3.1/Zeo-IRF5-4D (29) was digested with BamHI followed by a Klenow fill-in reaction and EcoRI cleavage. The resulting IRF5-4D fragment was cloned into the vector MSCV-IRES-CFP (a gift of F. Rosenbauer, Institute of Molecular Tumor Biology, University of Münster, Germany) via EcoRI and XhoI (the latter converted to a blunt end by Klenow fill-in). Sequences for IRF5 siRNAs were selected based on previously described design rules (48) . siRNA constructs were generated by cloning target sequences siRNA_2113 5′-GAGTGAGCACTTAGGTATCAT-3′ (siIRF5 #1) and siRNA_1025 5′-GTGGAACTCTTCGGCCCCATA-3′ (siIRF5 #2) through BglII and HindIII restriction sites into pSUPER (47) . The scrambled siRNA construct has been previously described (8) . All constructs were verified by sequencing.
Motif Discovery, Heatmaps, and Distributions. We used the findMotifsGenome function in Homer for primary motif detection, where de novo discovery was performed in regions ranging [−200bp ; +200bp] around the maximum DHS. Motif reinjection was carried out in RSA Tools Matrix-Scan (49) . Resulting outputs were converted to gff format and subsequently computed as frequencies every 10 bp for all regions and ordered according to fold changes. Heatmaps were generated via Java Treeview. Motif densities were computed relative to each DHS maximum, where distances used were that between the start of each motif (regardless of the strand) and the DHS maximum. Motif distances to NF-κB were obtained using BedTools closest and plotted in R.
DNaseI Digestion. To perform DNaseI accessibility assays with HRS and NH cell lines, the optimal cell number and DNaseI (DPFF DNaseI; Worthington Biochemical Corporation) concentration were titrated for each cell line. The DNA digestion extent was comparable in all of the generated samples as measured by RT-PCR (10). Briefly, 1 × 10 6 to 5 × 10 6 cells were permeabilized with detergent and immediately digested at 3 × 10 7 cells per mL for 3 min at 22°C with DNaseI at 1-12 U/mL in digestion buffer supplemented with 1 mM CaCl 2 (10) . The nuclei were lysed, the nuclear proteins were digested with 1 mg/mL Proteinase K overnight at 37°C, and the DNA was isolated by phenol/chloroform extraction. Levels of DNaseI digestion were assessed using real-time PCR, measuring the ratio of presence of known DNaseI hypersensitive regions to more resistant gene-free regions. Sequences of realtime PCR primers used were, for the active region, TBP promoter 5′-CTGGCGGAAGTGACATTATCAA and 5′-GCCAGCGGAAGCGAAGTTA, and for the inactive region, a gene free control region of chromosome 18: 5′-ACTCCCCTTTCATGCTTCTG and 5′-AGGTCCCAGGACATATCCATT. DNaseI-Seq samples were generated from a size selection of DNaseI-digested DNA fragments comprised within a range of 100-600 bp and subjected to library preparation as per the manufacturer´s instructions (Illumina). Libraries were run on an Illumina GAIIx sequencer. More detailed information is provided in SI Appendix, SI Methods.
